March 11, 2016
BIOPHYTIS receives positive scientific advice on SARCOB BIO101 clinical development plan from Belgian regulatory authority. Download the Press Release
BIOPHYTIS receives positive scientific advice on SARCOB BIO101 clinical development plan from Belgian regulatory authority. Download the Press Release
American LifeSci Capital initiates coverage of Biophytis stock. Téléchargez le communiqué de presse. Téléchargez le communiqué de presse
Biophytis to present at the Biotech Showcase conference run parallel to the JP Morgan Healthcare Conference (San Francisco, January 11-13, 2016). Read the Press Release
Biophytis Appoints of Roger A. Fielding, Ph.D., as a Scientific Consultant for Company’s SARCOB Clinical Development Program. Download the Press Release
Biophytis Appoints Pierre J. Dilda as Director of Research. Read the Press Release
Biophytis to present preclinical proof of concept for Sarcob to treat sarcopenic obesity at SCWD on December 4th. Download the Press Release
Biophytis establishes Boston subsidiary to accelerate clinical development. Download the Press Release
BIOPHYTIS Invited to Attend the Jefferies 2015 Global Healthcare Conference. Read the press release
BIOPHYTIS initiates the clinical batches production of BIO101, the first step in the ongoing phase 2b trial in the sarcopenic obesity. Click here to download the Press Release